About Disto Pharmaceuticals
Disto Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2002. It develops and manufactures pharmaceutical pellets, granules, tablets, and capsules. It operates on a B2B model. The company has 75 employees. Its Indian entity Disto Pharmaceuticals Private Limited reported revenue of ₹22.63 Cr. Disto Pharmaceuticals offers products and services including Pellets, Granules, Tablets, and Capsules. Its focus areas include R&D Services, Drug Development, Modified Release and Pharmaceuticals.
Company details
Disto Pharmaceuticals is a privately held company based in Hyderabad, India, focusing on the development and manufacturing of semi-finished formulations like pellets and granules, as well as finished formulations such as tablets and capsules. They emphasize high-quality production in ISO 9001 and GMP approved facilities, with expertise in modified-release technologies. The company serves pharmaceutical clients through committed schedules and competitive pricing, ensuring reliable supply.
- Headquarters Hyderabad, India
- Employees 75
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website distopharma.com
- Legal Name Disto Pharmaceuticals Private Limited
- Date of Incorporation 09 May, 2002
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹22.63 Cr
FY 2024 · -5% YoY
- Net Profit₹10.1 Lakh
FY 2024 · 0% margin
- EBITDA₹2.70 Cr
FY 2024 · 12% margin
- Employee Count75
Associated legal entities of Disto Pharmaceuticals
Disto Pharmaceuticals operates through Disto Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Disto Pharmaceuticals Private Limited CIN U24239TG2002PTC038926 | Active | 09 May 2002 | Hyderabad, Telangana | ₹22.6 Cr | 75 | 4 | View details |
Products & Services of Disto Pharmaceuticals
Disto Pharmaceuticals offers a comprehensive portfolio of products and services, including Pellets, Granules, Tablets, and Capsules.
Specialized pellets for pharmaceutical drug development.
Granules used in creating pharmaceutical formulations.
Solid oral dosage tablets for various therapeutic uses.
Solid oral dosage capsules with modified-release options.
Board of directors of Disto Pharmaceuticals Private Limited (Disto Pharmaceuticals)
Disto Pharmaceuticals Private Limited is the primary company behind Disto Pharmaceuticals. The board of Disto Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Asith Kumar Mukherjee, appointed in 2009. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Asith Kumar Mukherjee DIN 02778442 | Managing Director | 15 Sep 2009 | 17 yrs 1 mo | Disto Pharmaceuticals Private Limited |
| Harish Chandra Pandey DIN 03121956 | Director | 15 Sep 2009 | 17 yrs 1 mo | Disto Pharmaceuticals Private Limited |
| Bidesh Mukherjee DIN 09110363 | Whole-time director | 15 Oct 2022 | 4 yrs | Disto Pharmaceuticals Private Limited |
| Krishna Raj Pandey DIN 09110207 | Whole-time director | 15 Oct 2022 | 4 yrs | Disto Pharmaceuticals Private Limited |
Financials of Disto Pharmaceuticals
Figures of Disto Pharmaceuticals Private Limited, the primary company behind Disto Pharmaceuticals, for FY 2024. Revenue was ₹22.63 Cr (-5% year on year). Net profit was ₹10.1 Lakh (0% margin). EBITDA was ₹2.70 Cr (12% margin). Revenue has grown at a compounded annual rate of +8% over three years and +8% over five years.
- ₹22.63 CrRevenue · FY 2024 · -5% YoY
- ₹10.1 LakhNet profit · 0% margin
- ₹2.70 CrEBITDA · 12% margin
- ₹4.56 CrPaid-up capital
- 75Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Disto Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Disto Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Disto Pharmaceuticals
Disto Pharmaceuticals was founded in 2002.
Disto Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Disto Pharmaceuticals has 75 employees.
The primary company behind Disto Pharmaceuticals, Disto Pharmaceuticals Private Limited, reported revenue of ₹22.63 Cr for FY 2024, down 5% year on year.
Disto Pharmaceuticals is a privately held company based in Hyderabad, India, focusing on the development and manufacturing of semi-finished formulations like pellets and granules, as well as finished formulations such as tablets and capsules. They emphasize high-quality production in ISO 9001 and GMP approved facilities, with expertise in modified-release technologies. The company serves pharmaceutical clients through committed schedules and competitive pricing, ensuring reliable supply.
Disto Pharmaceuticals offers Pellets, Granules, Tablets, and Capsules.
Disto Pharmaceuticals operates through Disto Pharmaceuticals Private Limited.
The legal entities of Disto Pharmaceuticals currently have 4 directors, including Asith Kumar Mukherjee, Harish Chandra Pandey, Bidesh Mukherjee and others.